Lululemon founder commits $100M to cure his rare disease
Chip Wilson may be best known as the founder of athleisure brand Lululemon. But he’s now coming with another hidden identity: someone diagnosed with a rare disease known as facioscapulohumeral muscular dystrophy type 2.
The entrepreneur is going public with his own story as he unveils a $100 million commitment into a new venture called Solve FSHD, whose stated goal is to find a cure for the ailment by 2027.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.